CARDIOVASCULAR RISK-FACTORS IN CHRONIC-RENAL-FAILURE AND HEMODIALYSIS POPULATIONS

被引:249
|
作者
MA, KW
GREENE, EL
RAIJ, L
机构
[1] VET ADM MED CTR, DEPT MED, 1 VET DR, MINNEAPOLIS, MN 55417 USA
[2] UNIV MINNESOTA, MINNEAPOLIS, MN 55455 USA
关键词
CARDIOVASCULAR RISK FACTORS; CHRONIC RENAL FAILURE; HYPERTENSION; DYSLIPOPROTEINEMIA; LVH; GLUCOSE INTOLERANCE;
D O I
10.1016/S0272-6386(12)80827-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease is the leading cause of death in patients with end-stage renal disease (ESRD). Risk factors for cardiovascular disease, including hypertension, lipid abnormalities, left ventricular hypertrophy (LVH), and glucose intolerance, are present more frequently in patients with chronic renal failure than in the general population, even before the onset of replacement therapy. The prevalence, pathogenesis, and significance of these factors in the uremic population are examined, and the potential roles of intervention are reviewed. Evidence suggests, but is not conclusive, that these factors are of predictive value for cardiovascular complications in patients with chronic renal failure. The effect of modification of these factors on cardiovascular morbidity and mortality in this population, especially in the early stages of renal failure, is an important area for further study. © 1992, National Kidney Foundation. All rights reserved.. All rights reserved.
引用
收藏
页码:505 / 513
页数:9
相关论文
共 50 条
  • [21] ASSESSMENT OF UNDERWEIGHT PATIENTS WITH CHRONIC-RENAL-FAILURE ON HEMODIALYSIS
    SUNG, KH
    LEE, IH
    PARK, MCH
    KANG, CM
    PARK, HC
    KIDNEY INTERNATIONAL, 1992, 41 (05) : 1465 - 1465
  • [22] EFFECTS OF CHRONIC-RENAL-FAILURE AND HEMODIALYSIS ON PLASMA GLOMERULOPRESSIN
    ZHOU, XJ
    VAZIRI, ND
    KAUPKE, CJ
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1993, 16 (04): : 180 - 184
  • [23] CHRONIC-RENAL-FAILURE IN PATIENTS ON ACETATE AND BICARBONATE HEMODIALYSIS
    SHOSTKA, GD
    TYAGI, S
    TERAPEVTICHESKII ARKHIV, 1991, 63 (08) : 89 - 93
  • [24] SERUM THYROGLOBULIN IN CHRONIC-RENAL-FAILURE - EFFECTS OF HEMODIALYSIS
    HEGEDUS, L
    FELDTRASMUSSEN, U
    ANDERSEN, JR
    POULSEN, LR
    HANSEN, JM
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1987, 47 (01): : 35 - 40
  • [25] PHARMACOKINETICS OF TINIDAZOLE IN CHRONIC-RENAL-FAILURE AND IN PATIENTS ON HEMODIALYSIS
    FLOUVAT, BL
    IMBERT, C
    DUBOIS, DM
    TEMPERVILLE, BP
    ROUX, AF
    CHEVALIER, GC
    HUMBERT, G
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (06) : 735 - 741
  • [26] AMYLOID ARTHROPATHY IN PATIENTS WITH CHRONIC-RENAL-FAILURE ON HEMODIALYSIS
    GOMEZ, JM
    GOMEZ, R
    LLOPART, E
    CASES, A
    LOPEZPEDRET, J
    REVERT, L
    KIDNEY INTERNATIONAL, 1987, 32 (04) : 624 - 624
  • [27] CONTINUOUS HEMODIALYSIS IN THE TREATMENT OF EMERGENCIES IN CHRONIC-RENAL-FAILURE
    COTERA, A
    LORCA, E
    SAFFIE, A
    SEPULVEDA, M
    REVISTA MEDICA DE CHILE, 1992, 120 (12) : 1388 - 1392
  • [28] MULTIPLE KERATOACANTHOMAS ASSOCIATED WITH CHRONIC-RENAL-FAILURE AND HEMODIALYSIS
    TEMMERMAN, L
    DECLIPPELE, M
    DERMATOLOGICA, 1982, 165 (05): : 510 - 510
  • [29] PROPHYLACTIC BICARBONATE HEMODIALYSIS IN PREGNANCY WITH CHRONIC-RENAL-FAILURE
    RYCKELYNCK, JP
    ANDRE, M
    MULLER, G
    MERY, PB
    NEPHROLOGIE, 1983, 4 (4-5): : 208 - 209
  • [30] Risk factors of cardiovascular diseases and chronic renal failure
    Belyalov, FI
    KARDIOLOGIYA, 2005, 45 (07) : 92 - 96